Delivery Order SPE2DB24D2012-SPE2DB25FBWXM
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Progesterone 200 mg capsules (100-count units) with a ceiling value of $7,071.62. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The contract is set for ultimate completion by August 20, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Progesterone 200 mg capsules (100-count units) on September 8, 2025, with a ceiling value of $25,826.89. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 9, 2025. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order valued at $17,049.73 to AmerisourceBergen Drug Corp for the supply of Progesterone 200 mg capsules (100-count units). This firm fixed-price contract, awarded on August 27, 2025, with an ultimate completion date of August 28, 2025, represents a non-competitive set-aside delivery against AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to the company's corporate office...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Progesterone 200 mg capsules (100 count) with a ceiling value of $6,136.78. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and carries an ultimate completion date of September 9, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Progesterone 200 mg capsules (100-count units) with a ceiling value of $32,993.69. This is a firm fixed-price delivery order with an ultimate completion date of August 4, 2025, and represents a non-set-aside award made through competitive procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Progesterone 200 mg capsules (100 count) with a ceiling value of $1,563.57. This non-set-aside, firm fixed price delivery order was awarded on August 27, 2025, with an ultimate completion date of August 28, 2025. The pharmaceutical product will be supplied from AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Progesterone 200 mg capsules (100-count units) with a contract ceiling value of $7,427.51. This firm fixed-price delivery order, with an ultimate completion date of August 25, 2025, represents a competitively awarded, non-set-aside contract executed through AmerisourceBergen's existing pharmaceutical supply vehicle with the federal government. The product will be delivered...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Progesterone 200 mg capsules in quantities of 100 units. This firm fixed-price delivery order, valued at $10,748.99, is scheduled for completion by September 2, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award was made on a non-set-aside basis through competitive procurement procedures, reflecting...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Progesterone 200 mg capsules (100-count packages) valued at $1,227.10 under a firm fixed-price contract. The delivery order was competitively awarded without set-aside provisions and is scheduled for completion by August 18, 2025. AmerisourceBergen will fulfill this requirement from its corporate office location in Conshohocken, Pennsylvania, serving the military healthcare supply chain. This delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Progesterone 200 mg capsules (100-count units) on August 12, 2025, with a contract ceiling value of $1,669.70. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of August 13, 2025. The work is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's...
- SPE2DB24D2012Indefinite Delivery Contract
- SPE2DB24D2012-SPE2DB25FBWXMDelivery Order
The Defense Logistics Agency awarded a $7,553.65 firm fixed price delivery order to AmerisourceBergen Drug Corp for Progesterone 200 mg capsules (100 count) on September 8, 2025, with an ultimate completion date of September 9, 2025. The award was made through open competition with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and running through December 2026. The prime IDV serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen's demonstrated capability to fulfill federal medical supply requirements through competitive procurement, combined with its extensive portfolio across multiple therapeutic domains, positions it as a key supplier within the DLA's pharmaceutical supply chain supporting the Defense Health Agency and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.6k | 9/8/25 |